Ani Pharmaceuticals Inc (ANIP)

SG&A Expenses

$91.66M

Quarterly · Period ending: · USD

ANIP logo

ANIP SG&A Expenses

Latest reported$91.66M
ANIP Quarterly SG&A Expenses ($157.54K → $91.66M)
High-resolution chart · PNG

ANIP sg&a expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Ani Pharmaceuticals Inc SG&A Expenses — Quarterly (USD)
Period endingSG&A Expenses (USD)
497,972
465,058
653,907
416,219
307,280
301,175
157,539
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.